Rising medicinal use On one July, 2023, the Therapeutic Merchandise Administration amended its scheduling of copyright substances to enable the prescription of psilocybin for use in copyright assisted psychotherapy for procedure-resistant melancholy. Trials as to their usefulness and safety in managing several psychiatric problems are ongoing.Micr